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Introduction. Kidney ischemia-reperfusion (I/R) injury is the main cause of delayed graft function in solid organ transplantation.
Sonchus oleraceus is a plant with well-known antioxidant and anti-inflammatory activities; however, its effects on renal I/R are
unknown. Objective. To evaluate whether S. oleraceus extract (S.O.e.) has nephroprotective activity in an I/R model in Wistar
rats. Materials and Methods. Animal groups (n = 6): sham, I/R (45min/15 h), S.O.e (300mg/kg p.o.), and S.O.e + I/R (300mg/kg,
p.o.; 45min/15 h). Renal function, proinflammatory cytokines, alanine aminotransferase, markers of oxidative stress, and
histology were evaluated. Results. None of the mediators evaluated differed significantly between the S.O.e and sham groups.
Levels of blood urea nitrogen (BUN), creatinine, malondialdehyde (MDA), and proinflammatory cytokines were higher, and
superoxide dismutase (SOD) was lower in the I/R group than in the sham group. Histology showed tubular epithelial necrosis in
the medulla and cortex in the I/R group. In the S.O.e + I/R group, S.O.e pretreatment attenuated the I/R-induced increases in
BUN, creatinine, MDA, and proinflammatory cytokines induced, SOD was maintained, and histology showed discontinuous
necrosis in the medulla but no necrosis in the cortex. Conclusions. S.O.e was neither hepatotoxic nor nephrotoxic. S.O.e.
pretreatment showed a nephroprotective effect against I/R.
1. Introduction
Kidney injury caused by ischemia-reperfusion (I/R) is a sig-
nificant clinical problem and is considered to be the main
cause of acute renal failure, which can result from shock, par-
tial nephrectomy, or renal transplantation and can lead to
morbidity and mortality [1, 2]. Multiple pathogenic factors
contribute to the eventual death of kidney cells as a result
of I/R, including excessive oxidative stress, actions of proin-
flammatory cytokines, recruitment of inflammatory cells,
and apoptosis [2, 3]. Excessive oxidative stress is caused
mainly by reactive oxygen species (ROS) produced during
reperfusion and released as part of the inflammatory
response. ROS can damage cell organelles and change the
oxidation-reduction balance. The action of antioxidants,
such as reduced glutathione and enzymes such as superoxide
dismutase (SOD), is essential to reducing tissue damage.
Plants have been shown to be potential therapeutic agents
to protect against renal I/R. Experimental studies in rats have
reported that the primary mechanism through which plant
extracts prevent kidney damage induced by I/R involves
counteracting the effects of excessive oxidative stress through
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free radical-scavenging and antioxidant capacity [4, 5].
Sonchus oleraceus is a plant of the Asteraceae family and is
distributed worldwide. Many Sonchus species are used by
diverse cultures for the treatment of stomach pain, hepatitis,
infections, headache, rheumatism, cancer, warts, ulcers,
spider and snake bites, and inflammation [6–9]. In Mexico,
S. oleraceus is known as Achicoria dulce, cerraja, lechuguilla,
muela de caballo, and falso diente de león [10]. Throughout
the world, it is known as sow thistle or pūhā [11, 12]. Recent
research has shown that an S. oleraceus extract (S.O.e)
exhibits several types of bioactivity, including anxiolytic [6],
anti-inflammatory [7, 9], antibacterial [8], antioxidant [8,
11, 13, 14], antitumor [15], antinociceptive [16], and antiag-
ing [12] activities.
Given the reported antioxidant activity and potential
pharmacological properties, the aim of the current investiga-
tion was to evaluate whether S. oleraceus has a nephroprotec-
tive effect against I/R-induced injury in Wistar rats.
2. Material and Methods
2.1. Extract Preparation. The plant was collected in García,
NL, Mexico, during the summer of 2014 and authenticated,
and a voucher specimen (UAN-2429) was deposited in the
institutional herbarium located at the School of Biology of
the Universidad Autónoma de Nuevo León. The S. oleraceus
aerial part was dried at room temperature for 2 weeks and
then finely ground. The extract was obtained using Soxhlet
extraction. Briefly, 100 g of dried material was extracted in
1 L of ethanol for 5 h, and the extracted material was filtered
and concentrated under reduced pressure at 37°C, dried in an
oxygen-free environment at 37°C, and stored at 4°C until use;
the recovery was 3.3%.
2.2. Animals. Animal procedures were performed in accor-
dance with the proper use and care of laboratory animals
and according to the specifications of the Mexican Official
Norm NOM-062-ZOO-1999 and were approved by the
ethics committee of our institution (HI17-00002). Experi-
ments were performed using male Wistar rats weighing
200–300 g (Círculo A.D.N. S.A. de C.V., Mexico City,
Mexico). Animals were kept under standard conditions
such as a stable room temperature (24± 3°C) and 12 h
light-dark cycle and had access to commercial rat pellets
and water ad libitum.
2.3. Experimental Design. To evaluate whether treatment
with S.O.e at a dose of 300mg/kg could reduce kidney
injury after I/R, the following experimental groups were
evaluated (n = 6 per group).
The sham group was treated with the extract vehicle (3%
Tween-20) for 7 days, after which the rats received a sham
laparotomy without affecting the renal pedicle.
The S.O.e group was treated with 300mg/kg of extract for
7 days according to the report by Li et al. [9], after which the
rats received the same surgical procedure as the sham group.
The I/R group was treated with the extract vehicle for 7
days, after which acute kidney injury was induced by I/R
(45min ischemia + 15 h reperfusion).
The S.O.e + I/R group was treated with 300mg/kg of
extract for 7 days, after which the kidney injury was induced
by the same procedure as the I/R group.
2.4. Induction of Kidney Injury. Rats were anesthetized using
xylazine (Sedaject; Vedilab S.A. de C.V. Reg. SAGARPA Q-
0088-122) by intraperitoneal injection at a dose of 10mg/kg
of body weight with ketamine as an analgesic (Anesket; PiSA
Agropecuaria, S.A. de C.V. Reg. SAGARPA Q7833-028) by
intraperitoneal injection at a dose of 100mg/kg of body
weight according to the suppliers’ specifications.
The I/R and S.O.e + I/R groups received a laparotomy to
expose both kidneys. Kidney injury was induced by ischemia
caused by 45min of occlusion of the renal pedicle used vascu-
lar clamps, after which the clamps were withdrawn and
reperfusion was allowed for 15 h. During this period, rats
were allowed access to food and water ad libitum. For the
sham and S.O.e groups, the surgical procedure involved a
laparotomy without any occlusion.
Blood samples were taken from rats after the surgical
procedure and centrifuged at 3500 rpm for 15min. The
serum was separated and was used to measure the levels of
alanine aminotransferase (ALT), renal function markers,
and proinflammatory cytokines. Kidney tissue samples were
obtained immediately after the blood samples were taken.
One part of the tissue was fixed in 10% formaldehyde for
histopathological evaluation, and the other was frozen at
−80°C for measurement of malondialdehyde (MDA) and
SOD levels.
2.5. Biochemical Analysis, Proinflammatory and Oxidative
Stress Markers. Blood urea nitrogen (BUN), creatinine con-
centration, and ALT activity were determined by spectropho-
tometry (ILab Aries; Instrumentation Laboratory, Milan,
Italy) using commercial kits (Instrumentation Laboratory)
according to the supplier’s specifications.
The concentrations of proinflammatory cytokines were
measured using a commercial enzyme-linked immunosor-
bent assay for rat interleukin 6 (IL-6), interleukin 1-beta
(IL-1β), and tumor necrosis factor-alpha (TNF-α) (Pepro-
Tech, Mexico City, Mexico). Avidin-horseradish peroxidase
conjugate was used to oxidize 2,2′-azino-bis(3-ethylbenzo-
thiazoline-6-sulfonic acid), which produced a chromogen
whose concentration was proportional to the concentration
of the cytokine being evaluated. The measurements were
made spectrophotometry at 405nm.
The concentration of MDA, the final product of lipid per-
oxidation, was measured using a thiobarbituric acid-reactive
substance (TBARS) assay using a TBARS Assay Kit (Cayman
Chemical Company, Ann Arbor, MI, USA). To measure
MDA concentration, 100μL of the supernatant from
medium or standard, 100μL of sodium dodecyl sulfate, and
4mL of the color reagent were added to each vial. The vial
was heated at 100°C for 1 h and then immediately cooled in
an ice bath and centrifuged at 11,000 rpm for 15min at 4°C.
Next, 150μL from each vial was transferred to each well in
a microplate. The absorbance of the product was measured
at a wavelength of 540nm on a microplate reader. The extent
of lipid peroxidation was quantified by estimating the MDA
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concentration. The results are expressed as micromoles of
MDA equivalents formed per liter.
SOD activity was measured using a Superoxide Dismut-
ase Assay kit (Cayman Chemical Company) and a colorimet-
ric assay to measure the concentration of formazan crystals at
450nm. This assay uses a tetrazolium salt for the detection of
superoxide radicals generated by xanthine oxidase and hypo-
xanthine. To measure SOD activity, 200μL of the diluted
radical detector and 10μL of the supernatant of tissue
homogenate or standard were added to each well of a
96-well plate, and 20μL of xanthine oxidase was added.
Absorbance in the well was measured at a wavelength of
460nm after 20min on a microplate reader (Thermo Sci-
entific Multiskan FC, Waltham, USA). The results are
expressed as IU/mL. One IU of SOD is defined as the
amount of enzyme needed to exhibit 50% dismutation of
the superoxide radical.
2.6. Evaluation of Renal Histopathology. Kidneys were fixed
in a 10% buffered formaldehyde solution (pH7.4). A repre-
sentative sample was taken from both kidneys of all rats in
the four groups. The tissue was processed routinely and par-
affin embedded. Paraffin blocks were cut using a microtome
at a thickness of 4μm, and the sections were deparaffinized,
hydrated, and stained with hematoxylin and eosin (H&E).
The sections were examined under a microscope for the pres-
ence of indicators of cellular damage such as tubular necrosis
and eosinophilic casts, which are regarded as semiquantita-
tive measures. A scoring system was used to evaluate kidney
histopathology as follows: no damage =0; mild damage =1
(unicellular patchy isolated damage); moderate damage =2
(damage <25%); severe = 3 (damage 25–50%); severe = 4
(>50% damage) [17].
2.7. Statistical Analysis. The data are expressed as mean
± standard deviation (SD) and were analyzed by one-way
analysis of variance followed by the Tukey test for multi-
ple comparisons or Kruskal-Wallis nonparametric test
using Prism software (v. 6.0; GraphPad, San Diego, CA,
USA). Differences between means were considered signifi-
cant at p < 0 05.
3. Results
3.1. Study of the Toxicity of the Plant Extract In Vivo. There
were no significant differences between the sham and S.O.e
groups in the levels or activities of ALT (86± 7 IU/L versus
90± 6 IU/L), BUN (12± 2mg/dL versus 13± 1mg/dL), creat-
inine serum (0.53± 0.33mg/dL versus 0.50± 0.22mg/dL),
MDA (247± 20μM versus 304± 21μM), SOD (1082± 54U/
mL versus 1179± 28U/mL), and IL-6 (Figure 1, Table 1).
The concentrations of IL-1β and TNF-α were significantly
higher in the sham group than in the S.O.e group (Table 1).
3.2. Effect of S. oleraceus Extract on Kidney Injury Induced by
I/R. The BUN and creatinine levels were significantly higher
in the I/R group than in the sham group (83± 16mg/dL ver-
sus 12± 2mg/dL; 2.92± 0.35mg/dL versus 0.53± 0.33mg/dL,
respectively; p < 0 0001) (Figure 1). In the group pretreated
with S. oleraceus before ischemia (S.O.e + I/R group), the
increases in BUN and serum creatinine levels were signif-
icantly attenuated: 83± 16mg/dL versus 60± 21mg/dL,
respectively (p = 0 0297) and 2.92± 0.35mg/dL versus
1.57± 0.51mg/dL, respectively (p < 0 0001) (Figure 1).
MDA level was significantly higher in the I/R group
than in the sham group (1422± 166μM versus 247± 20μM;
p < 0 0001). S. oleraceus treatment significantly attenuated
the increase in MDA level in the S.O.e + I/R group
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Figure 1: Changes in renal function tests and markers of oxidative stress. (a) BUN, (b) creatinine, (c) MDA, and (d) SOD levels before and
after I/R. Values are expressed as mean± SD.
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compared with the I/R group (789± 58μM versus 1422±
166μM; p < 0 001) (Figure 1).
SOD level was significantly lower in the I/R group than in
the sham group (959± 88U/mL versus 1082± 54U/mL; p =
0 0275). In the S.O.e + I/R group, SOD levels were preserved
to compared at I/R group (1191± 231U/mL; p = 0 0198)
(Figure 1).
The TNF-α, IL-1β, and IL-6 concentrations were
significantly higher in the I/R group than in the sham
group (p < 0 004). The cytokine concentrations were signif-
icantly lower in the S.O.e + I/R group than in the I/R
group (p < 0 007) (Table 1).
3.3. Evaluation of Renal Histopathology. The scoring system
used for evaluation of kidney histopathology is shown in
Table 2. The mean score for tissue damage was significantly
higher in the I/R group than in the sham group. Kidneys of
rats treated with S. oleraceus exhibited less damage, as shown
by lower scores, compared with the I/R group. Light micro-
scopic examination of H&E-stained tissue sections showed
normal renal parenchyma, tubules, and glomeruli in the
sham and S.O.e groups. By contrast, kidney tissues from the
I/R group showed tubular epithelium necrosis in the medulla
and cortex. Kidney tissues from the S.O.e + I/R group showed
discontinuous necrosis in the marrow and conserved cortex
(Figure 2).
4. Discussion
When an extract is proposed as a possible therapeutic
strategy, it is necessary to demonstrate that it is not toxic.
To rule out any possible hepatotoxic or nephrotoxic effects
of the extract, we measured the levels of ALT, BUN, creat-
inine, SOD, and MDA in the S.O.e group. The extract had
no measurable effects on these variables, as shown by the
similar levels of these mediators in the treated and sham
groups. This agrees with the findings by other investiga-
tions that S. oleraceus has no cytotoxic effect in vitro or
in vivo [9, 18].
Renal ischemia cannot be prevented in some clinical
situations such as renal transplantation, traumatic shock,
sepsis, postpartum hemorrhage, or major surgery. I/R-
induced kidney injury occurs when the blood flow to an
organ is stopped temporarily and blood is then reperfused
with oxygenated blood to the organ. This process triggers
the release of ROS, one of the main causes of the tissue injury
caused by reperfusion [2, 19, 20]. This tissue injury stimulates
an inflammatory response mediated mainly by neutrophils
and macrophages, which then release proinflammatory
mediators such as cytokines [1]. This inflammatory response
directly affects renal function as shown by an increase in the
serum concentrations of BUN and creatinine. Some plants
with antioxidant activity have been reported to decrease
the secondary damage caused by oxidative stress produced
by kidney I/R (which affects kidney function) [21, 22]. In
this study, we found that the pretreatment with S.O.e. atten-
uated the increases in serum of BUN and creatinine levels
compared with those observed in the I/R group. This finding
suggests that S.O.e. may have a nephroprotective effect,
which may be related to its antioxidant activity as reported
by others [8, 11, 13, 14, 18, 23].
Proinflammatory cytokines participate in an important
pathway involved in I/R-induced renal injury. IL-6 release
increases the degree of injury, dysfunction, and renal inflam-
mation; this cytokine promotes the expression of adhesion
molecules and consequent oxidative stress [24]. TNF-α, a
potent proinflammatory cytokine, has been shown to reduce
glomerular perfusion by inducing the synthesis of vasocon-
strictor and vasodilator mediators [25]. IL-1β has been
described as a chemoattractant that recruits leukocytes to
the areas of renal inflammation, which leads eventually to
kidney damage [26]. Treatment with an extract of S. olera-
ceus has been reported to have an anti-inflammatory effect
in several models. In a recent in vitro model of the RAW
264.7 mouse macrophage cell line, an extract of S. oleraceus
had an anti-inflammatory effect after stimulation with lipo-
polysaccharide, as shown by significant decreases in the levels
of IL-1β, IL-6, and TNF-α. This study also reported a
decreased inflammatory response to in vivo xylene-induced
edema with an extract dose of 300mg/kg [9]. In our study,
the significantly higher IL-1β, IL-6, and TNF-α levels in the
I/R group than in the sham group indicated the presence of
an inflammatory response. Pretreatment with S.O.e. at a dose
of 300mg/kg significantly attenuated this increase in IL-1β,
IL-6, and TNF-α levels in the S.O.e + I/R group through
effects on the inflammatory response.
Recent phytochemical investigations of S. oleraceus have
identified secondary metabolites such as sesquiterpene lac-
tones, taraxasterol, luteolin, apigenin, caftaric acid, chicoric
acid, villosol, ferulic acid, β-sitosterol, ursolic acid, rutin,
β-daucosterin, and others [9, 13, 27]. Of these secondary
metabolites, several bioactive molecules may be involved
Table 1: Concentrations of proinflammatory cytokines in the
experimental groups.
Experimental groups
IL-6
(ng/mL)
IL-1β
(ng/mL)
TNF-α
(ng/mL)
Sham 0.14± 0.03 0.86± 0.13 0.42± 0.07
I/R 0.37± 0.06∗ 1.36± 0.09∗ 0.77± 0.15∗
S.O.e 0.13± 0.05 0.61± 0.11∗ 0.29± 0.10∗
S.O.e + I/R 0.11± 0.05∗∗ 0.64± 0.19∗∗ 0.42± 0.09∗∗
Data are presented as mean ± S.D. ∗Sham versus study group (P < 0 004),
∗∗I/R versus S.O.e + I/R (P < 0 007).
Table 2: Mean scores for total tissue damage in the experimental
groups.
Experimental groups
Parameters
Tubular necrosis Eosinophilia casts
Sham 0.50± 0.75 0.00± 0.00
I/R 4.00± 0.00∗ 2.25± 0.95∗
S.O.e 0.50± 0.54 0.00± 0.00
S.O.e + I/R 2.77± 0.66∗∗ 1.44± 0.52∗∗
Data are presented as mean ± S.D. ∗P < 0 05 as compared with Sham,
∗∗P < 0 05 as compared with I/R.
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in vasoprotection from the endothelial injury induced by I/R.
Examples include rutin, which exhibits anti-inflammatory
activity because of its free radical-scavenging and antioxidant
capacities [28]; β-sitosterol, which significantly inhibits the
TNF-α-induced expression of adhesion molecules that play
key roles in the inflammatory process and interfere with
multiple signaling pathways including cell cycle, apoptosis,
proliferation, and metastasis [29, 30]; apigenin, which atten-
uates the inhibition of vasorelaxation induced by pyrogallol
[31] and exerts anti-inflammatory activity by modulating
nuclear factor κB activity, reducing inflammatory cytokine
production and limiting neutrophil migration toward the
inflammatory microenvironment [32]; and luteolin, a potent
inhibitor of inflammation that may also help to ensure
endothelial integrity [33]. These actions suggest that the
anti-inflammatory effect observed in the S.O.e + I/R group
may relate to the presence of some of these molecules
described in this plant.
Reperfusion after ischemia increases the release of ROS,
which are important effectors of cellular injury [18]. Free
radicals participate in the physiopathology of renal I/R injury
[2]. Cellular antioxidant enzymes such as SOD block the free
radical effect; however, overwhelming of these protective
activities by excessive production of free radicals causes lipid
peroxidation, whose end product is MDA [34, 35]. In our
study, treatment with S. oleraceus attenuated the oxidative
injury produced by renal I/R, as shown by the increase in
SOD activity and decrease in MDA activity. This effect may
reflect the antioxidant activities described for somemolecules
contained in extracts of S. oleraceus as rutin, luteolin, and
chicoric acid [11, 13].
Several studies have reported characteristic lesions of I/R-
induced renal injury [1, 3–5, 19–21]. In our study, ischemia
for 45min and reperfusion of 15 h caused damage to renal
tissue, as shown by measures of renal dysfunction such as
diffuse tubular necrosis and abundant protein-like intratubu-
lar eosinophilic cylinders. S.O.e. attenuated the renal injury
produced by the I/R, as shown by discontinuous necrosis in
the medulla and conserved cortex.
5. Conclusion
Our results indicate that S.O.e. was neither hepatotoxic nor
nephrotoxic and that pretreatment with S.O.e. markedly
attenuated postischemic damage to rat kidneys. Treatment
with S.O.e. attenuated the increase in proinflammatory cyto-
kine levels and markers of renal damage and oxidative stress.
Our study provides a basis for further identification of which
molecules are responsible for this apparent nephroprotective
activity of S. oleraceus. This is the first report of nephropro-
tective activity of S.O.e against I/R-induced injury.
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